India continues to face an alarming rise in air- and water-borne diseases, driven by rapid urbanization, population growth, ...

CANDID-CNS™ is the new state-of-the-art AI model for BBB penetration: it achieves 87% AUPRC on bRo5 small molecules compared to 56% by Pfizer’s ...

Clinical trials for drug development are notoriously slow and expensive, and only a small fraction of drug candidates end up being approved by the regulatory authorities. The extensive bottlenecks in ...

BOSTON, Dec. 05, 2025 (GLOBE NEWSWIRE) -- 1910, the only AI-native biotech pioneering small and large molecule therapeutics discovery, today announced that its CANDID-CNS (TM) AI model has been ...

Spatial RNA medicine combines transcriptomics and RNA therapeutics, mapping gene expression in tissues to enhance precision ...

The Faculty of Life Sciences & Medicine at King's has launched a new master's programme in Biotechnology and Computational ...

Advanced technologies in pharma manufacturing necessitate a redefinition of the Qualified Person's role, focusing on digital ...